Thursday | 8 January, 2009
Australian Biotechnology News

Stories about: XOMA

  • +

    The pharmaceutical forecast 05/04/2005 14:38:04

    A new environment for pharmaceutical companies is on the horizon and it will be the fittest who survive, predicts Ian Nisbet.
  • +

    Amgen submits psoriasis drug for marketing review 09/07/2003 14:00:00

    Amgen, the world's No. 1 biotechnology company, said it has asked US regulators to approve the sale of its rheumatoid arthritis drug, Enbrel, to treat the skin disorder psoriasis.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links